Positron emission tomography imaging of D2/3agonist binding in healthy human subjects with the radiotracer [11C]‐N‐propyl‐norapomorphine: Preliminary evaluation and reproducibility studies
- 19 March 2009
- Vol. 63 (7) , 574-584
- https://doi.org/10.1002/syn.20633
Abstract
Objective: (−)‐N‐[11C]‐propyl‐norapomorphine (NPA) is a full dopamine D2/3receptor agonist radiotracer suitable for imaging D2/3receptors configured in a state of high affinity for agonists using positron emission tomography. The aim of the present study was to define the optimal analytic method to derive accurate and reliable D2/3receptor parameters with [11C]NPA.Methods: Six healthy subjects (four females/two males) underwent two [11C]NPA scans in the same day. D2/3receptor‐binding parameters were estimated using kinetic analysis (using one‐ and two‐tissue compartment models) as well as simplified reference tissue method in the three functional subdivisions of the striatum (associative striatum, limbic striatum, and sensorimotor striatum). The test–retest variability and intraclass correlation coefficient were assessed for distribution volume (VT), binding potential relative to plasma concentration (BPP), and binding potential relative to nondisplaceable uptake (BPND).Results: A two‐tissue compartment kinetic model adequately described the functional subdivisions of the striatum as well as cerebellum time‐activity data. The reproducibility ofVTwas excellent (≤10%) in all regions, for this approach. The reproducibility of both BPP(≤12%) and BPND(≤10%) was also excellent. The intraclass correlation coefficients of BPPand BPNDwere acceptable as well (>0.75) in the three functional subdivisions of the striatum. Although SRTM led to an underestimation of BPNDvalues relative to that estimated by kinetic analysis by 8–13%, the values derived using both the methods were reasonably well correlated (r2= 0.89,n= 84). Both methods were similarly effective in detecting the differences in [11C]NPA BPNDbetween subjects.Conclusion: The results of this study indicate that [11C]NPA can be used to measure D2/3receptors configured in a state of high affinity for the agonists with high reliability and reproducibility in the functional subdivisions of the human striatum. Synapse 63:574–584, 2009.Keywords
This publication has 40 references indexed in Scilit:
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding RadioligandsJournal of Cerebral Blood Flow & Metabolism, 2007
- Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C]raclopride in healthy humansHuman Brain Mapping, 2007
- First Human Evidence of d-Amphetamine Induced Displacement of a D2/3 Agonist Radioligand: A [11C]-(+)-PHNO Positron Emission Tomography StudyNeuropsychopharmacology, 2007
- Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C] N-Propyl-norapomorphine and [11C]Raclopride in BaboonsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐racloprideSynapse, 2004
- (−)-N-[11C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D2 receptorsNuclear Medicine and Biology, 2000
- Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humansSynapse, 1999
- Cocaine abusers do not show loss of dopamine transporters with ageLife Sciences, 1997
- S-(+)-aporphines are not selective for human D3 dopamine receptorsCellular and Molecular Neurobiology, 1994
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974